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SUMMARY
Nuclear factor κB (NF-κB) RelA is the potent transcriptional activator of inflammatory response 
genes. We stringently defined a list of direct RelA target genes by integrating physical (chromatin 
immunoprecipitation sequencing [ChIP-seq]) and functional (RNA sequencing [RNA-seq] in 
knockouts) datasets. We then dissected each gene’s regulatory strategy by testing RelA variants in 
a primary-cell genetic-complementation assay. All endogenous target genes require RelA to make 
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DNA-base-specific contacts, and none are activatable by the DNA binding domain alone. 
However, endogenous target genes differ widely in how they employ the two transactivation 
domains. Through model-aided analysis of the dynamic time-course data, we reveal the gene-
specific synergy and redundancy of TA1 and TA2. Given that post-translational modifications 
control TA1 activity and intrinsic affinity for coactivators determines TA2 activity, the differential 
TA logics suggests context-dependent versus context-independent control of endogenous RelA-
target genes. Although some inflammatory initiators appear to require co-stimulatory TA1 
activation, inflammatory resolvers are a part of the NF-κB RelA core response.
Graphical Abstract
In Brief
Ngo et al. developed a genetic complementation system for NF-κB RelA that reveals that NF-κB 
target-gene selection requires high-affinity RelA binding and transcriptional activation domains 
for gene induction. The synergistic and redundant functions of two transactivation domains define 
pro-inflammatory and inflammation-response genes.
INTRODUCTION
An important concept is molecular biology is the modular domain organization of 
transcription factors (TFs) (Keegan et al., 1986), typically distinguishing between a DNA-
binding domain (DBD) and a separable transcriptional activation domain (TAD) that could 
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be fused to a heterologous DBD. Prominent mammalian TFs, including nuclear factor κB 
(NF-κB) RelA (Schmitz and Baeuerle, 1991; Schmitz et al., 1994), conform to the modular 
domain model. Such studies used exogenous reporter genes that provided a convenient assay 
for TF activity. However, they lacked the physiological context of endogenous regulatory 
regions, which may involve complex protein-protein interactions and are often considerable 
distances from the transcription start site. Indeed, subsequent studies provided numerous 
examples in which the functional distinction between DNA binding and transcriptional 
activation did not neatly segregate into distinct structural domains, with the DBD providing 
transcriptional activity (Corton et al., 1998) or, conversely, not being required for TF 
recruitment to the target gene (Kovesdi et al., 1986).
Given that the regulatory context of endogenous target genes determines a TF’s mode of 
function, next-generation TF structure-function studies may be considered probes of the 
regulatory diversity of its endogenous target genes. However, only with the advent of 
quantitative transcriptomic and epigenomic measurement capabilities enabled by next-
generation sequencing has it become feasible to undertake such studies. The present study is 
leveraging such technological development to dissect the regulatory strategies of 
inflammatory response genes that are regulatory targets of NF-κB RelA.
The NF-κB family member RelA is a ubiquitously expressed potent transcriptional activator 
that is induced by exposure to pathogens and inflammatory cytokines to activate the 
expression of many inflammatory and immune-response genes (Hayden and Ghosh, 2008; 
Hoffmann and Baltimore, 2006). The signaling mechanisms involved in regulating NF-κB 
RelA activity have been elucidated in detail (Basak et al., 2012; Mitchell et al., 2016), but 
there is much more uncertainty about how it controls endogenous target genes. Indeed, 
although many genes have been identified to be potentially regulated by NF-κB (http://
www.bu.edu/NF-kb/gene-resources/target-genes/), there is no database that lists the NF-κB 
target genes in a particular physiological condition, defined cell type, and stimulus.
RelA’s domain organization is characterized by the Rel homology region (RHR), which 
mediates dimerization and DNA binding functions (Baeuerle and Baltimore, 1989) and was 
structurally characterized by X-ray crystallography (Chen et al., 1998a, 2000). However, it is 
possible that for some endogenous target genes, promoter recruitment of RelA is mediated 
primarily by protein-protein interactions, for example, via pre-bound CREB-binding protein 
(CBP) (Mukherjee et al., 2013).
RelA’s C terminus contains two transactivation domains, TA1 and TA2 (Ballard et al., 1992; 
Moore et al., 1993; Schmitz and Baeuerle, 1991), which interact with transcriptional 
regulatory factors. TA1 consists of an amphipathic helix characteristic of an acidic activation 
domain and can interact with MED80 subunit of the Mediator complex, Tfb1/p62 subunit of 
TFIIH, and CBP via the kinase-inducible domain interacting (KIX) domain (van Essen et al., 
2009; Lecoq et al., 2017; Mulero et al., 2019). TA2 also interacts with CBP/p300 but via the 
TAZ1 domain with sufficient affinity that it could be characterized by nuclear magnetic 
resonance (Mukherjee et al., 2013; Nyqvist et al., 2019), as well as MED80. The RHR was 
reported to interact with CBP as well via phosphorylated S276 (Zhong et al., 2002), and 
knockin mutations of the S276A or S276E mutation showed complex mouse phenotypes and 
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transcriptional defects (Dong et al., 2008). It also remains possible that trans-activation of 
some target genes is mediated by other sequences within RelA, for example, between RHR 
and TA2/TA1.
Interestingly, a key difference between TA1 and TA2 is the role of post-translational 
modification (PTM). Unlike TA2, TA1’s conformation is thought to be regulated (Savaryn et 
al., 2016) by phosphorylation of any of seven potential sites (S529, Ser535, S536, S543, 
S547, S550, and S551 in human RelA) altering cofactor interactions (Milanovic et al., 2014) 
and, hence, transcriptional activation potential (Hochrainer et al., 2013). In particular, S536 
is a prominent phospho-acceptor site (Christian et al., 2016), which is a reliable biomarker 
for RelA activity. This suggests a model in which TA1’s transactivation activity is dependent 
on a phosphorylation event that integrates the activity of other signaling pathways, such as 
CKII, CaMKIV, RSK1, TAK1/TAB1, PI3K/Akt, ATM, and IKKε (Bae et al., 2003; Bao et 
al., 2010; Bird et al., 1997; Bohuslav et al., 2004; Buss et al., 2004a; Haller et al., 2002; 
Moreno et al., 2010; Sabatel et al., 2012; Sakurai et al., 2003; Wang et al., 2000; Yoboua et 
al., 2010), whereas TA2’s transactivation potential is intrinsic to its biochemical structure. 
Remarkably, however, it remains unknown whether NF-κB response genes show differential 
regulation by TA1 versus TA2; this is an important question because TA2-regulated genes 
would be expected to provide for a core NF-κB-mediated inflammatory response, whereas 
TA1-regulated genes are dependent on other signaling pathways as well.
Here, we report the stringent identification of endogenous NF-κB target genes induced by 
tumor necrosis factor (TNF) in primary fibroblasts and a genetic complementation system 
for RelA variants to probe their regulatory strategies. We found that all RelA target gene 
binding was dependent on base-specific contacts within the κB sequence, and all 
transactivation was dependent on the two C-terminal activation domains; neither the 
transcriptional activation domain nor did the DNA binding domain proved sufficient for 
target gene selection or transcriptional activation, respectively. However, we discovered 
remarkable gene-specific regulatory strategies involving the transcriptional activation 
domains TA1 and TA2. Although most genes were regulated by both TA1 and TA2, the two 
transactivations functioned either redundantly or synergistically, forming logical OR-or-
AND gates in a gene-specific manner. Although OR gate genes were robustly activated by 
the constitutive TA2 activity, on AND gate genes TA2’s role is to boost the PTM-regulated 
TA1 activity. Thus, our study distinguishes NF-κB RelA target genes as being either largely 
signaling context independent or largely signaling context dependent.
RESULTS
Stringent Identification of TNF-Responsive NF-κB RelA Target Genes
To identify high-confidence NF-κB RelA target genes, we applied two rigorous criteria, 
namely (1) TNF-induced NF-κB/RelA binding to the target gene’s regulatory regions, and 
(2) TNF-induced transcriptional activation that is genetically dependent on NF-κB. To 
examine the genome-wide binding pattern of NF-κB, we performed chromatin 
immunoprecipitation followed by sequencing (ChIP-seq) with RelA-specific antibodies 
during a short course of TNF stimulation of 0, 0.5, and 3 h in wild-type (WT) primary 
murine embryonic fibroblasts (MEFs). Bioinformatic analysis of the replicate datasets 
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(false-discovery rate [FDR] < 0.01) identified in 9,829 RelA peaks that were TNF-inducible 
at 0.5 or 3 h (Figure 1A). Overall, these ChIP-enriched RelA binding events were notably 
enhanced at 0.5 h and largely remained at 3 h (Figure 1B, left panel). We identified the 
locations of these RelA peaks to be 44% in intergenic regions, 17% within promoter regions 
(comprising 5 kB upstream of the transcription start site), 36% within intronic regions, and 
3% within exonic regions of genes (Figure 1B, right panel). Genome browser tracks of two 
known NF-κB target genes, Nfkbia and Cxcl10, confirmed easily discernible peaks above a 
low background, and those peaks were highly inducible in response to TNF and highly 
reproducible between the two datasets (Figure 1C).
To assess the NF-κB-dependent transcriptional response to TNF, we performed gene 
expression analysis of nascent transcripts via chromatin-associated RNA sequencing 
(caRNA-seq) in WT and crel−/− rela−/− MEF cells (Figure 1D). We chose caRNA-seq 
analysis rather than polyA+ RNA-seq to ensure that we identified transcriptional induction, 
rather than changes in mRNA levels mediated by post-transcriptional mechanisms, for 
example, changes in the mRNA half-life. Previous work has shown that the absence of RelA 
can be partially compensated for by the NF-κB family member cRel (Hoffmann et al., 
2003), necessitating the use of the combination knockout to assess RelA-dependent gene 
expression. Our 1-h analysis revealed 419 TNF-inducible genes in WT MEFs whose caRNA 
levels were more than 2-fold induced in WT MEFs at any time point after TNF stimulation 
relative to the unstimulated (0 h) point (Figure 1D). Setting the maximum reads per kilobase 
of transcripts per million mapped reads (RPKM) for each gene to 1 and the basal RPKM in 
unstimulated WT cells to be 0, we plotted data from crel−/− rela−/− MEF cells next to WT 
data. We found that 259 genes had peak expression values that were less than half in the 
mutant relative to WT, and 160 genes showed expression that was more than half, leading us 
to label the former as largely “NF-κB dependent” and the latter largely “NF-κB 
independent.” Motif-enrichment analysis of the regulatory DNA regions associated with 
transcription start sites (TSSs) with HOMER (Heinz et al., 2010) revealed a preponderance 
of κB sites in the NF-κB-dependent genes but no highly significant motif for NF-κB-
independent genes (Figure 1E). Focusing on those that are protein coding (229 and 120, 
respectively), we undertook gene ontology (GO) analysis with Enrichr Ontologies (Kuleshov 
et al., 2016) for over-represented functional pathways in each category. We found that the 
top five most highly enriched GO terms (by p value) for the NF-κB-dependent genes 
described the inflammatory response and NF-κB activation (Figure 1E), whereas the NF-
κB-independent genes did not yield highly significant terms. Line graphs of two NF-κB-
dependent genes, Nfkbia and Cxcl10 (Figure 1F), exemplify the high degree of NF-κB 
dependence in their TNF-induced expression.
To develop the list of stringent NF-κB RelA-regulated target genes, we intersected the 
above-described physical/binding data (within 10 kB of each gene’s TSS) and the genetic/
functional data and further ensured that the nascent transcripts were indeed processed into 
mature mRNAs by performing polyA+ RNA-seq from total RNA isolated from WT MEF 
cells in response to TNF, extending our time analysis to 3 h (0.5, 1, and 3 h time points). 
Selecting for peak fold change in response to TNFs of ≥2, an FDR of <0.01 and ≥50% NF-
κB dependence of the maximum value in the time course, we generated a list of 113 
stringently selected NF-κB/RelA-regulated target genes (Figure 1G). The replicate datasets 
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showed a high level of concordance. The corresponding caRNA-seq data (Figure 1H) 
indicate that, aside from the very early gene group, the timing of the peak mRNA abundance 
may not be driven by transcriptional mechanisms but, rather, by post-transcriptional 
mechanisms, such as mRNA processing (Pandya-Jones et al., 2013) or mRNA half-life (Hao 
and Baltimore, 2009). Mapping the RelA ChIP-seq data associated with each gene (Figure 
1I) identified probable RelA binding events responsible for gene induction but did not reveal 
a correlation between RelA binding location and transcriptional induction dynamics.
An Experimental System to Dissect Regulatory Strategies of NF-κB RelA Target Genes
To characterize the regulatory strategies of NF-κB RelA-target genes by probing them for 
their requirements of RelA functional domains, we developed an experimental workflow for 
retroviral complementation of RelA-deficient MEF cells with specifically engineered 
variants of RelA and performed subsequent transcriptomic analysis in response to TNFs. To 
prolong the lifespan of primary MEFs (Todaro and Green, 1963), which would otherwise not 
be amenable for such genetic manipulation, we investigated whether we could use MEFs 
deficient in p53. Transcripts induced by TNF, interleukin (IL)-1β, or lipopolysaccharide 
(LPS), revealed similar gene expression patterns between two biological replicates of p53-
deficient MEFs and their littermate WT controls (Figure S1A). Pairwise comparisons 
revealed high reproducibility in inducible gene expression between p53−/− and WT MEFs at 
each time point (Figures S1B–S1E), justifying the use of p53-deficient MEFs for studies of 
inflammatory response genes.
To develop the primary MEF RelA complementation system, we bred knockout mouse 
strains to produce a strain that was not only deficient in NF-κB subunits but also in p53, 
which allowed production of primary p53−/− crel−/− rela−/− MEF cells from E12.5 embryos 
(before embryonic lethality of this genotype at E13). After expansion of these cells for about 
a week, we retrovirally transduced them with RelA-wt (Figure 2A), selected transduced cells 
with puromycin, and examined complementation by biochemical assays. Immunoblotting 
revealed RelA expression in reconstituted cells at about the same level as WT control MEFs 
(Figure S2A). An electrophoretic mobility shift assay (EMSA) with a κB site probe showed 
strong DNA binding activity after TNF stimulation (Figure S2B).
To further test the genetic complementation system, we examined NF-κB RelA binding via 
RelA ChIP-seq using RelA-wt reconstituted MEFs with and without 0.5 h of TNF 
stimulation on previously identified endogenous NF-κB target genes (Figure 1G), such as 
Nfkbia and Cxcl10 (Figure 2B). Importantly, we found that RelA-binding peaks identified in 
WT MEF controls were indeed also present in the reconstituted RelA-wt cells (Figure 2C).
Next, we examined gene expression responses to TNF in reconstituted MEFs stimulated 
with TNF using polyA+ RNA-seq. We found high reproducibility in replicate reconstituted 
MEFs on Nfkbia and Cxcl10 (Figure 2D). Extending our analysis to the 113 NF-κB target 
genes, a scatterplot analysis demonstrated good correlations in polyA+ RNA expression 
patterns between WT MEF controls and the reconstituted RelA-wt MEFs at each time-point 
analysis (Figure S2C). Specifically, we found that 104 genes satisfied the same criteria 
applied to WTs and crel−/− rela−/− MEFs, namely TNF fold-change over time of ≥2, an FDR 
of <0.01, and ≥50% NF-κB dependence of the maximum expression value in the time-
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course (Figure 2E), thereby validating the primary MEF complementation system. In sum, 
our analysis revealed 104 NF-κB target genes (Table S1) that showed robust RelA DNA 
binding and RelA-dependent, TNF-inducible expression at both nascent and mature mRNA 
transcript level.
All TNF-Induced NF-κB Target Genes Require that RelA Makes Base-Specific Contacts 
within the κB Element
Prior structural and functional studies of NF-κB-DNA complexes demonstrated that NF-κB 
binds to a variety of κB sites, in which NF-κB recognizes 9–11-bp palindromic κB DNA 
elements to the sequence 5′-GGR(N3–5YCC)-3′ (Hoffmann et al., 2006). Using that 
information, we identified all κB DNA elements that were associated with all identifiable 
RelA ChIP-seq peaks (Figure 1I) for each of the 104 genes (Table S1). Mapping the RelA 
ChIP-seq data and κB DNA elements associated with each gene within 10 kB of their TSSs 
(Figure 2F), we found κB DNA elements for 223 RelA binding peaks on 104 genes. Those 
223 RelA binding events harbor 617 full-κB and 12,768 half-κB DNA elements with an 
FDR of <0.01. When the FDR is relaxed to <0.05, then the 234 RelA binding events are 
identified as harboring 663 full-κB and 14,072 half-κB DNA elements, and the conclusions 
are confirmed (Figure S2D). Overall, we did not observe a correlation between the relative 
affinity of the κB site sequence determined by in vitro protein-binding-DNA microarrays 
(Siggers et al., 2011) and the number of reads within a peak (Figure S2E).
To determine whether DNA-base-specific contacts of the RelA protein are in fact required 
for recruiting NF-κB to target sites and for activating target genes upon inflammatory 
stimulation, we generated a triple amino acid mutation (R35A, Y36A, and E39A), depicted 
in Figure 3A, termed the RelA DNA-binding mutant (RelADB). The mutations abrogate 
base-specific contacts within the κB sequence (Figure 3B; Chen et al., 1998a). We retro-
virally transduced that DNA-binding mutant into primary p53−/− crel−/− rela−/− MEFs and 
examined the NF-κB by biochemical assays. Immunoblotting confirmed expression of 
reconstituted RelADB protein, albeit at slightly lower levels (about 75%) than found with 
RelA-wt (Figure 3C). Co-immunoprecipitation confirmed that the RelADB mutant was able 
to associate with p50 to form dimeric NF-κB and to interact with p105, IκBα, and IκBβ to 
form higher-order IκB-NF-κB complexes, characteristic of latent NF-κB in unstimulated 
cells (Figure S3A). We next assessed the NF-κB DNA-binding activity via EMSA and found 
that RelADB showed no κB-site-binding activity in response to TNF stimulation, unlike the 
RelA-wt control (Figure 3D), although immunoblotting of the nuclear extracts confirmed the 
nuclear presence (Figure S3B). In sum, the RelADB mutant does not support high-affinity 
NF-κB DNA-binding in vitro.
We next examined NF-κB RelA binding in vivo by RelA ChIP-seq. On previously identified 
9,829 endogenous chromatin sites (Figure 1A), the RelADB mutant showed dramatically 
diminished TNF-induced RelA binding (Figure 3E). For example, on Nfkbia and Cxcl10 
genes, TNF-induced RelA binding was dramatically reduced (Figure S3C). Focusing on the 
104 NF-κB target genes (Figure 2E), we evaluated every previously identified RelA binding 
peak and found that most showed a substantial >2-fold reduction in the RelADB mutant 
(Figure 3F). Detailed differential RelA ChIP peak analysis (Table S1) revealed that those 
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few RelA peaks that were less affected by the RelADB mutant were generally less prominent 
in WT cells (Figure 3G), which we interpreted to be indicative of the strong contribution of 
high-affinity DNA binding ability. Furthermore, they generally showed poorer κB site 
motifs, as quantified by in vitro protein-DNA microarray studies (Figures 3H and S3D). 
Overall, our analysis reveals that NF-κB RelA selects most inflammatory-response target 
genes via direct RelA-DNA interactions via base-specific contacts.
Next, we investigated whether the reduced κB recruitment of the DNA binding mutant 
results in a diminished transcriptional response from the NF-κB target genes. We performed 
polyA+ RNA-seq in reconstituted MEFs stimulated with TNF over a 3-h course analysis 
(0.5, 1, and 3 h). Examining the model target genes, Nfkbia and Cxcl10, we found that the 
RelADB mutant did not support their gene expression (Figure S3E). Extending the analysis 
to the 104 NF-κB target genes, we found that the TNF-induced gene expression response 
was almost entirely abolished in the RelADB mutant cells (Figure 3I). This is also evident in 
a principal-component analysis (PCA) of the 104 genes (Figure S3F), which shows that the 
transcriptional response of the mutant largely overlaps with the empty vector control. Only 
one gene retained 50% transcriptional activation, Rrad (Ras-related glycolysis inhibitor and 
calcium channel regulator). Close examination revealed some residual RelA binding within 
the promoter region (Figure S3G), including a κB binding site at −123 bp (5′-
GGGAATCCCC-3′), whose 4G stretch could provide sufficient affinity to heterodimeric 
NF-κB via the p50 binding partner (Cheng et al., 2011).
In sum, our analysis showed that for most genes the triple amino acid mutation abrogates 
TNF-induced in vivo DNA binding (RelA ChIP data) and target gene expression. Our results 
suggest that RelA target-gene selection depends on base-specific interactions between RelA 
and the κB site; our data do not rule out that protein-protein interactions with chromatin-
bound factors contribute to binding-site selectivity but indicate that such interactions do not 
suffice for the activation of inflammatory response NF-κB target genes.
All TNF-Induced NF-κB Target Genes Are Regulated by Two C-Terminal TA Domains
To investigate the role of RelA’s C-terminal region in the transcriptional activation of 
endogenous NF-κB target genes, we first generated two truncated, variant forms of murine 
RelA: a full truncation of its C-terminal region (deleting aa 326–549; Δ326–549), referred to 
as C-termΔ; and a deletion specifically of its two TA domains (deleting residues 429–549; 
Δ429–549), referred to as TADΔ (Figure 4A).
Immunoblotting of reconstituted MEFs showed close to WT expression of the TADΔ mutant 
but slightly lower levels of RelA, IκBα, and IκBβ in the C-termΔ mutant (Figure 4B). 
Nevertheless, NF-κB DNA-binding activity was detected by EMSA at comparable levels to 
that of reconstituted RelA-wt controls (Figure 4C). Upon stimulation, both mutants showed 
a normal onset of TNF-inducible binding activity of NF-κB; however, post-induction 
repression characteristic of TNF-induced NF-κB activity was abrogated, indicative of 
defective negative-feedback control. Indeed, no TNF-induced Nfkbia mRNA expression was 
observed in either mutant (Figure 4D).
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Extending the analysis to RNA-seq data of the 104 NF-κB target genes, the PCA plot 
showed that both mutations result in severe deficiency in TNF-induced gene-expression 
response (Figure 4E), largely equivalent to the empty vector (EV) control. Single-gene 
analysis by heat-map visualization confirmed that global picture (Figure 4F): none of the 
104 genes showed normal TNF induction, with only one gene, Slfn2, being induced to about 
50% in the TADΔ mutant. In sum, despite the elevated TNF-induced NF-κB activity in these 
mutant cells (because of deficient negative feedback control), the data indicate that all 
transcriptional activation functions of NF-κB require the C-terminal activation domains TA1 
and TA2.
To determine whether NF-κB target genes have differential requirements for either TA1 or 
TA2, we constructed variants of RelA (Figure 5A), a deletion mutant lacking residues 520–
549 that define the TA1 (hereafter is referred to as TA1Δ); a double amino acid mutant 
L449A and F473A, which abrogates the RelA TA2 function of interacting with the TAZ1 
domain of transcriptional coactivator, CBP/p300 (Mukherjee et al., 2013), referred to as 
(TA2CI); and a double mutant (TA2CITA1Δ). (Internal deletion of TA2 appeared to disrupt 
the function of TA1, which prompted us to design point mutations within the domain.) After 
reconstitution of p53−/− crel−/− rela−/− MEFs, we confirmed that expression levels of RelA 
variants and the canonical IκBs were close to those in RelA-wt control (Figure 5B). Further, 
gel-mobility shift analysis confirmed that those targeted mutations did not interfere with NF-
κB dimerization, activation, and DNA binding to κB sites upon TNF stimulation (Figure 
5C). However, similar to C-termΔ and TADΔ mutants examined previously, we found that 
NF-κB DNA-binding activity was persistent over the 3-h time, indicative of a loss of proper 
negative-feedback control. Indeed, TNF-induced Nfkbia mRNA expression was 
substantially diminished in single mutants and abrogated in the double mutant (Figure 5D).
To extend the gene expression analysis to the 104 NF-κB target genes, we analyzed RNA-
seq data for all described mutants. PCA revealed that both single mutants showed global 
deficiencies in the TNF-induced gene expression response, whereas the double mutant 
appeared almost entirely deficient in transcriptional activation, akin to the complete TADΔ 
mutant (Figure 5E). Interestingly, visualizing the data at single-gene resolution in the 
heatmap format (Figure 5F) revealed subtle differences in the functionality of the mutants 
that warranted a quantitative analysis.
A Model-Aided Analysis Reveals Gene-Specific Logic Gates Formed by RelA TA1 and TA2
For each RelA target gene to assess the functional requirements of TA1 and TA2 
quantitatively, we had to address the potentially confounding effect of alterations in the NF-
κB activation time course (Figure 5C). We developed a mathematical formalism that 
considered both the measured time courses of mRNA and the NF-κB DNA-binding activity 
that drives transcription; hence, an ordinary differential equation (ODE) model of RelA-
dependent gene expression was constructed (Figure 6A). The model consists of a single 
ODE representing the rate of change of the mRNA that resulted from NF-κB-driven 
synthesis and mRNA decay (see Method Details). NF-κB-driven mRNA synthesis is a 
function of the amount of NF-κB DNA binding activity and the specific activation activity 
(kact) of the particular RelA variant.
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Given the DNA binding activity measured for each RelA TA mutant, we could identify the 
activation rate (kact) for each gene that optimally accounts for the measured mRNA profile 
(Figure 6B). Other parameters (KD, nhill, kdeg) were also fit but assumed to be the same for 
all RelA variants because they represent intrinsic properties of the gene promoter of mRNA. 
Particle-swarm optimization was used to minimize the distance between simulated RNA 
time courses and the measured RNA-seq data for each of the 104 genes, and the model was 
able to recapitulate the experimental findings indicating that altered activation strengths 
associated with each TA mutant could explain the altered RNA-seq results (Figure 6C). A 
stringent criterion (ln(dist) < − 2:5, see Method Details) was applied to exclude 28 genes 
with unsatisfactory fits. For the remaining genes, a wide range of activation strengths (kact) 
values were identified for the TA1Δ and TA2CI mutants, from ~1 (in which TA mutation did 
not affect gene induction strength relative to RelA-wt) to 0 (where TA mutation of a single 
TA domain entirely abrogated gene expression) (Figure 6C).
Our hope for this analysis was to identify differences in relative dependence on TA1 versus 
TA2 among the 104 RelA target genes, and we found modest specificity: for example, 
inflammatory genes Cxcl2, Cd83, and Icam1 had greater TA1 dependence, whereas Pdlim4 
(Src inhibitor) and Gsap (protease) showed a higher degree of TA2 dependence. However, 
for many genes, the optimally parameterized kact values for TA1Δ and TA2CI mutants were 
correlated (Figure 6C) with marked differences in the degree of the decrease associated with 
both mutants (Figure 6D). For example, Cxcl1, Cxcl2, and Tnf, showed a substantial 
decrease in expression when mutating either TA domain (Figures 6D and 6E, bottom left), 
whereas Il15ra and Il1rl1 expression remained normal when either TA domain was removed 
(Figures 6D and 6E, top right). On the former class of genes, the inability of either TA 
domain to function effectively on its own suggests that TA1 and TA2 function 
synergistically, whereas, on the latter class of genes, they seem to function redundantly or 
independently. Thus, the unexpected conclusion from this analysis is that RelA target genes 
differ whether they impose an AND gate or an OR gate logic on the two TA domains within 
RelA. Given that the activity of TA1 is thought to be dependent on the phosphorylation 
status of serines in its amphipathic helix, an AND-versus-OR gate logic determines distinct 
regulatory role for TA2: in the latter case, TA2 may be primary driver of transcriptional 
activation, but in the former case, TA2 merely assists or boosts TA1-driven gene activation.
A Knockin Mouse Reveals that Regulatory Strategies of RelA Target Genes Are Generally 
Conserved in Different Cell Types but Are Often Stimulus Specific
The complementation of RelA-deficient primary MEF cells with mutated variants of RelA 
allowed us to study the effects of numerous specific mutations on the TNF response. To 
dissect regulatory strategies of endogenous target genes in other cell types and in response to 
other stimuli, we engineered a mouse strain that harbors the previously described RelA 
TA2CITA1Δ variant as a knockin mutation, termed RelATA (Figure S4A). Homozygous 
RelATA/TA mice are not embryonically lethal, unlike the RelA−/− mice, but are sickly and 
smaller than their heterozygous littermates (Figure S4B), whose genotype was verified by 
PCR (Figure S4C). To examine whether RelA target genes showed similar or differential 
regulatory strategies in other cell types and other inflammatory stimuli, we produced 
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extensive RNA-seq data by stimulating WT and RelATA/TA primary MEFs and bone-
marrow-derived macrophages (BMDMs) with TNF or Toll-like 4 receptor ligand LPS.
We first identified genes that were activated in both MEFs and BMDMs by a stringent log2 
fold-change >2 threshold (Figure 7A). We found 37 such genes in response to TNF and 481 
in response to LPS stimulation (Figure 7A). After peak-normalizing the data for each gene, 
we plotted the relative-expression data from WT and RelATA/TA MEFs and BMDMs in 
order of induction peak time in WT MEFs and subsequent hierarchical clustering (Figure 
7B). We found that most gene-activation events were diminished in both mutant MEFs and 
BMDMs. We evaluated the phenotype by plotting the percentage of expression in RelATA/TA 
cells relative to the WT peak expression at the same time point for each gene (Figure 7C). In 
MEFs, most genes were TA dependent (28/37), and most of those (25/28) were also TA 
dependent in BMDMs. In response to LPS, most genes were TA independent in both MEFs 
and BMDMs, given the strong activation of NF-κB-independent signaling pathways of 
IRF3/ISGF3 and MAPK p38. However, of the 154 genes that were identified as TA 
dependent in MEFs, ~90% showed an equivalent degree of TA dependence in BMDMs. 
These data suggest that regulatory strategies of RelA target genes are generally conserved in 
different cell types when induced by the same stimulus.
We then asked whether regulatory strategies of NF-κB target genes may be stimulus 
specific. To that end, we identified 146 genes that were induced by both TNF and LPS in 
MEFs and 185 that were induced by both stimuli in BMDMs (Figure 7D). Heatmap 
visualization of the gene expression time courses revealed that most genes induced rapidly 
by TNF peaked later in response to LPS (Figure 7E, left and right panels). Examining their 
RelA TA dependence by collapsing the data to the peak time point, we found that, of the 120 
MEF genes that were TA-dependent in response to TNF, only 60% showed an equivalent 
degree of TA dependence in response to LPS, and 15% were entirely TA independent 
(Figure 7F, left and right panels). Similarly, of the 26 genes whose TNF induction was TA 
independent, half showed TA dependence in response to LPS. In BMDMs, the lack of 
equivalence was even more pronounced: only 25% showed an equivalent degree of TA 
dependence (or independence) in response to TNF and LPS, and more than 40% showed 
entirely the opposite regulatory requirements for RelA’s TA domains.
We also assessed the 104 RelA target genes identified previously in the primary MEF RelA 
complementation system that were expressed in the knockin MEFs and BMDMs in response 
to TNF and LPS stimulations (Figure S5A). We found that all of those genes were induced 
in MEFs by >2-fold but not all of them were induced in BMDMs (grayed out rows marked 
by an asterisk), indicative of cell-type-specific epigenomes or enhancer landscapes. In 
response to TNF, induction of all 104 genes was almost entirely abrogated in the RelATA/TA 
MEFs (left panel), whereas in response to LPS, a small subset of genes remained induced.
We wondered whether compensation by cRel, which was documented in RelA−/− MEFs 
(Hoffmann et al., 2003), was affecting our results. We thus bred the RelATA knockin strain 
to a crel−/− background and produced RNA-seq data from crel−/− RelATA/TA and crel−/− 
MEFs in response to TNF and LPS stimulations. We found that all 104 target genes were 
induced by both TNF and LPS in crel−/− control MEFs (Figure S5A). Interestingly, in 
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response to LPS, those genes that showed induction in the mutant, by and large, also showed 
induction in the mutant in the crel−/− background. Further, expanding our view to all genes 
induced by both TNF and LPS by log2 fold change >2 (and maximum RPKM >1), we found 
146 genes in WT MEFs; of which, 145 also satisfied these stringent criteria induced in crel
−/−
 MEF controls. Our results with crel−/− RelATA/TA and RelATA/TA MEFs demonstrate that 
the lack of RelA TA dependence is generally not due to cRel compensation (Figure S5C).
The stimulus-dependent requirement of RelA TAs suggested that gene regulatory strategies 
are stimulus specific. To investigate whether that could be explained by the induction of 
distinct combinations of TFs, we performed motif-enrichment analysis. We found that 
regulatory regions of genes that were RelA TA dependent in response to both TNF and LPS 
were highly enriched for κB sites (Figure S5C, right panel). In contrast, genes that were TA 
dependent in the TNF, but not in the LPS, condition, showed enrichment also of interferon 
response factor (IRF) and PU.1:IRF8 binding sites, akin to previously identified the IRF-NF-
κB OR gate genes (Cheng et al., 2017). Further, the 26 genes that showed RelA TA-
independent induction in response to both TNF and LPS did not show enrichment to any 
stimulus-induced TFs. To further examine whether these TA-independent genes are also NF-
κB independent for their transcriptional response, we looked at their TNF response in p53−/− 
crel−/− rela−/− MEFs reconstituted with empty vectors and found that almost all showed 
substantial TNF induction (Figure S5D); whether the data for two outliers is reliable may 
require additional experiments, but generally, our results indicate that NF-κB’s capacity to 
induce inflammatory-response genes depends on RelA’s transactivation domain.
In sum, our transcriptomic analysis using newly developed RelATA/TA mice revealed that 
regulatory strategies of RelA target genes were generally conserved between MEFs and 
BMDMs when the same stimulus was used but that, in either cell type, RelA TA dependence 
observed in response to TNF was not always correlated with dependence in response to LPS, 
which also induces IRF family members. These data indicate that some NF-κB target genes 
are capable of engaging distinct regulatory strategies to different stimuli depending on the 
availability of stimulus-induced TFs (Cheng et al., 2017, 2015; Ourthiague et al., 2015).
DISCUSSION
In this study, we reveal gene-specific regulatory strategies of endogenous RelA target genes 
in primary cells by probing their stimulus-induced expression with engineered RelA 
variants. We stringently identified target genes by both functional and physical binding 
criteria, developed an experimental system to test mutational variants in primary cells, and 
systematically analyzed both chromatin DNA recruitment and transcriptional trans-
activation at single-gene resolution. A key transcriptional activation domain mutation was 
produced as a knockin mouse mutant line to examine other cell types and stimuli, and a 
mathematical modeling approach enabled a quantitative analysis to reveal gene-specific 
logic gates formed by the two TA domains.
We first showed that RelA recruitment and transcriptional activation of all endogenous NF-
κB target genes induced by TNF are dependent on DNA base-specific contacts. Akin to 
previous X-ray structural analysis of the NF-κB-DNA complex (Chen et al., 1998b), we 
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observed that some RelA binding events only contain half sites. Importantly, in our RelADB 
mutant analysis, the p50 dimerization partner may still contribute to DNA binding but that 
appears to be insufficient. Although the gene-expression response to TNF is rapid, future 
studies may address whether the dependence on DNA base-specific contacts also pertains to 
longer-term expression dynamics mediated by NF-κB.
Our studies further indicate that all endogenous target genes induced by TNF require the C-
terminal region of RelA that harbors two transactivation domains TA1 and TA2. That is 
remarkable given that S276 was reported to play critical roles in recruiting CBP/p300 
(Zhong et al., 1998), and knockin mutant mice harboring the S276A mutation showed 
striking animal phenotypes and alterations in the expression of many genes, including some 
known NF-κB target genes (Dong et al., 2008). Our analysis suggests that these mechanisms 
are insufficient for TNF-induced NF-κB target gene activation and may support the notion 
that the phenotype of S276 mutation may be due to alterations at larger time and epigenetic 
scales (Cheng et al., 2008).
By further probing target genes for the roles of the two C-terminal activation domains TA1 
and TA2, we found remarkable gene specificity. Target genes did not differ very much in 
whether they were more highly regulated by TA1 versus TA2, but they differed in whether 
they required either just TA or required both TAs for gene activation. In other words, some 
NF-κB target genes allow TA1 and TA2 to function independently, forming a logical OR 
gate, and some NF-κB target genes require the synergistic function of TA1 and TA2, with 
the TAs forming a logical AND gate. These distinct regulatory strategies may be mediated 
by distinct mechanistic requirements for the recruitment of molecular co-activators. For 
example, genes that exhibit an OR gate logic, are activated sufficiently by recruiting CBP/
p300 via TA2, but genes exhibiting an AND gate logic need not only recruit CBP/p300 but 
also additional co-activators via TA1.
The functionality of TA1 is thought to be regulated by PTMs, particularly phosphorylation, 
just as the transactivation potential of the NF-κB protein cRel is modulated by TNF-induced 
serine phosphorylation of S460 and S471 in a gene-specific manner (Starczynowski et al., 
2005). In contrast, TA2 is thought to have intrinsic transactivation activity via a high-affinity 
interaction with CBP/p300. However, within TA2, S467 was also reported as a potential 
phosphorylation site (Buss et al., 2004b; Geng et al., 2009; Mao et al., 2009; Schwabe and 
Sakurai, 2005). To investigate whether S467 has a role in the TNF induction of NF-κB target 
genes in fibroblasts, we constructed the S467A variant within full-length RelA, TA1-deleted 
RelA, or the CBP-interaction mutant TA2CI (Figure S6A). Gel-mobility shift analysis 
showed TA2S467A did not alter the DNA-binding activity of NF-κB compared with each 
respective parent construct (Figure S6B; cf. Figure 5C), and protein expression levels of 
those RelA variants and the canonical IκBα and IκBβ were normal (Figure S6C). We then 
undertook polyA+ RNA-seq analysis, and PCA revealed only minimal alteration in the TNF-
induced gene expression response with S467A in the WT or TA2CI context (Figure S6D). 
Furthermore, in a heatmap with single-gene resolution (Figure S6E), we observed very little 
effect by the S467A mutation. Only chemokines Cxcl1, Cxcl2, and Ccl20, which are rapidly 
and highly induced, showed a slight reduction but no enhancement. Our data thus confirm 
that an intrinsic CBP/p300 interaction affinity (probed with the TA2CI mutation) is the 
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primary mode of function of the TA2 domain. This contrasts with how TA1’s functionality is 
enhanced by phosphorylation events mediated by coordinated kinases, such as CKII and 
IKKε (O’Shea and Perkins, 2008; Buss et al., 2004a; Wang et al., 2000).
What are the implications of this regulatory distinction of TA1 versus TA2 for the 
transcriptional control of NF-κB target genes, which differ in how they employ TA1 and 
TA2? Considering NF-κB target genes that are regulated redundantly by TA1 OR TA2, we 
would expect them to respond to all inflammatory stimuli that activate the IKK-NF-κB axis 
because TA2 is effective for its induction, and regulated TA1 activity may merely provide 
some modulation. In contrast, NF-κB target genes that are regulated synergistically by TA1 
AND TA2 will be strongly activated only by those inflammatory stimuli that also induce the 
phosphorylation of TA1 serines that potentiate its acidic activation function and recruit other 
necessary regulatory cofactors for the synergistic activation to enhance their transcription 
through RelA (Blair et al., 1994; van Essen et al., 2009). Alternatively, TA1 phosphorylation 
may be a function of the microenvironmental context defined, thus rendering the activation 
of these gene’s tissue context dependent. We note, for such genes controlled by an AND gate 
of TA1 and TA2, the role of TA2 is effectively to amplify the effect of phosphorylation-
mediated regulation of TA1 in activity, rendering them more responsive to these PTMs then 
if they were regulated by only TA1.
To address why some genes may require the synergistic activity of two TAs, whereas others 
do not, we first analyzed the content of nucleosome-destabilizing CpG dinucleotides 
(Ramirez-Carrozzi et al., 2009) in promoter regions. We found that the top 25% target genes 
(11 genes) regulated synergistically by TA1 AND TA2 had a lower percentage of CG 
content within ±300 bp from their TSS than the bottom 25% (Figure S7A), supporting a 
model in which a more stable nucleosome is more restrictive to gene activation. (An 
alternative model is the co-regulatory function of GC-binding Sp1; Van Essen et al., 2009.) 
Interestingly, these genes also showed higher κB motif binding z-scores (Figure S7B), 
possibly leading to longer NF-κB residence times, which may allow both TA domains to be 
engaged in sequential activation mechanisms. Indeed, upon TNF stimulation, those genes 
showed higher RNA polymerase II (Pol II) ChIP signals at 0.5 and 3 h (Figure S7C), 
indicative of higher levels of transcriptional induction.
Examining the types of genes that are regulated redundantly, versus synergistically, by TA1 
and TA2, we are struck that many genes that provide for negative regulation of 
inflammation, such as Il15ra, IL1rl1, Trim47, Slfn2, or RelB fall into the former category. 
For those genes, TA redundancy means that they constitute an inflammatory core response 
that includes provisions for inflammatory resolution. In contrast, the latter category includes 
genes that are key initiators of an inflammatory response, such as TNF, Ccl20, Ccl2, and 
Cxcl1. For these genes, TA synergy means that their expression is activated only in response 
to a subset of inflammatory stimuli or when tissue-environmental context provides for the 
co-stimulatory signal that TA1 requires.
The here-described paradigm of NF-κB RelA-responsive gene expression being either 
redundantly or synergistically mediated by TA1 and TA2 should prompt a range of further 
studies that extend past work on the signals and pathways that control TA1 phosphorylation 
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and the molecular mechanisms that determine whether a target gene requires the dual 
TA1/TA2 functionality. We may imagine that the involvement of differential co-activators, 
mediator complexes, nucleosome movements, or other complex chromatin interactions or 
recruitment or release of RNA polymerase may have a role in determining diverse regulatory 
logics.
More broadly, the present study suggests that the structure-function relationship of key TFs 
provides an informative probe to dissect the diverse gene regulatory strategies that govern 
their dozens and hundreds of target genes. Quantitative datasets produced by next-generation 
sequencing allow a focus on endogenous genes that may be effectively, quantitatively 
evaluated not only bioinformatically (which evaluates average behavior, assuming 
commonalities) but also with gene-specific resolution by mathematical models of the gene-
expression process to reveal regulatory diversity. Thus, we hope that our study provides an 
analysis blueprint for future studies; indeed, advances of CRISPR/Cas9 technology that 
enable the engineering of variants into the endogenous gene locus is powering studies of 
endogenous gene regulatory circuits at single gene resolution.
STAR★METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Alexander Hoffmann (ahoffmann@ucla.edu). All plasmids 
generated in this study are available from the Lead Contact upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice—Wild-type and RelA, cRel, p53 gene-deficient C57BL/6 mice were maintained in 
pathogen-free conditions at the University of California, Los Angeles. The animal protocol 
for this study were approved by the Institutional Animal Care and Use Committee and by 
the University of California, Los Angeles Division of Laboratory Animal Medicine. 
Targeted Neo deleted RelA transactivation domain knock-in mutant mice were generated by 
ingenious Technology Lab (iTL, https://www.genetargeting.com). Wild-type primary MEFs 
were generated by crossing wild-type to wild-type mice at 8 weeks of age. p53−/− crel−/− 
rela−/− primary MEFs were generated by crossing p53−/− crel−/− rela+/ male mouse with 
p53−/− crel−/− rela+/ female mouse at 8 weeks of age. Wild-type or RelATA/TA primary 
MEFs were generated by crossing RelATA/+ (heterozygous allele) male mouse with 
RelATA/+ female mouse at 8 weeks of age.
Primary Cell Culture—Wild-type or mutant primary MEFs were generated from E11.5–
13.5 embryos of mixed gender and cultured in DMEM supplemented with 10% bovine calf 
serum (BCS), 1% penicillin-streptomycin and 1% L-Glutamine. BMDMs were made by 
isolating 5 × 106 bone marrow cells from mouse femurs of WT or RelATA/TA C57BL/6 mice 
following red blood cell lysis and seven-day culturing with 30% L929-conditioned medium.
Cell Lines—Platinum-E (Plat-E) retroviral packaging cell line, a modified cell line derived 
from HEK293T (Morita et al., 2000), were cultured in DMEM with 10% FBS supplemented 
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with 1% penicillin-streptomycin and 1% L-Glutamine, blasticidin (10 μg/mL) and 
puromycin (1 μg/mL).
METHOD DETAILS
Construction of mutant RelA plasmids—The pBABE-puro plasmid vector containing 
RelA was constructed by ligating the polymerase chain reaction (PCR)-amplified coding 
region of murine RelA (amino acids 1 to 549) restricted with EcoRI and SalI. Agilent 
QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies) was used for all RelA 
point mutation and deletion variants. DNA binding mutant (RelADB) within amino-terminal 
were mutated by a triple substitution at residues Arg35, Tyr36, and Glu39 to Ala (R35A, 
Y36A, R39A). Mutagenesis of the carboxyl-terminal region for C-termΔ, TADΔ, and TA1Δ 
were performed by displacing residues Pro326, Ala429, and Ser520, respectively, with a 
STOP codon sequence. All site-specific mutations were verified by Sanger sequencing 
analysis and sequencing analyses of the resulting RelA mutants showed that the targeted 
sites were the only changes in the DNA sequence.
Genetic complementation of MEFs—For transfection, Plat-E cells were plated on 10-
cm plates 16-hr the day before transfection at 50% confluent in DMEM supplemented with 
10% fetal calf serum, 1% penicillin-streptomycin and 1% L-Glutamine. Cells were 
transfected using 300 μL of Opti-MEM medium (ThermoFisher Scientific) and 
polyethylenimine (PEI; 1 μg/μL in 1xPBS pH4.5, Polysciences #23966–2) with 7 mg of 
retroviral construct DNA, pBABE-puro EV control or RelA expressing constructs (4:1 ratio 
of PEI (μL):plasmid DNA (μg)). Transfection complex (Opti-MEM medium, PEI reagent, 
plasmid DNA) were incubated for 20-min at room temperature then added drop-wise to Plat-
E cells for 6 hours. Transfected media was replaced with fresh DMEM media containing 
10% fetal calf serum, 1% penicillin-streptomycin and 1% L-Glutamine. Cells were further 
incubated for a total of 48-hr post-transfection and prior to collecting viruses. Viruses-
containing supernatant were filtered through a 0.45 mm filter and used to infect p53−/− crel
−/−
 rela−/− MEFs with the addition of 4 μg/mL Polybrene. 48-hr post-infection of cells with 
viruses the stably transduced cells were selected with 2 mg/mL puromycin for a total of 72 
hours. Post selection with puromycin, puromycin-containing medium was removed and cells 
are passaged twice for recovery prior to being expanded in culture for experiments. pBABE-
puro empty vector without the RelA gene fragment was used as a negative control, to 
maintain a stable retrovirally transduced RelA knockout cell line, meanwhile pBABE-puro 
containing full-length RelA (RelA-wt) was used as a positive RelA cell line control.
Western Blotting—For whole cell extracts, 3 × 106 cells were lysed with RIPA buffer 
containing 1mM PMSF and 1mM DTT followed by lysing with 1x SDS-PAGE sample 
buffer containing 5% β-mercaptoethanol. Protein extracts were separated by SDS-PAGE 
before transfer to nitro-cellulose membranes and subjected to western blotting. Nuclear and 
cytoplasmic extracts were performed with standard methods as described previously 
(Hoffmann et al., 2002; Werner et al., 2005). Western blots were probed with antibodies 
listed in the Key Resources Table and were visualized using SuperSignal West Femto and 
West Pico (1:10 mixture) Chemiluminescent reagents to detect chemiluminescence released 
by HRP-labeled secondary antibodies. The resulting proteins were visualized by ChemiDoc 
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XRS+ Imaging Systems (Bio-Rad) and Image Lab (Bio-Rad). Western blots of resulting 
proteins were quantified using ImageJ software (NIH, USA).
Electrophoretic mobility shift assay (EMSA)—EMSA was carried out with standard 
methods as described previously (Hoffmann et al., 2002; Werner et al., 2005). In brief, 2.5 
mL total normalized nuclear extracts were incubated for 15-min with 0.01pmol of P32-
labeled 38bp double-stranded oligonucleotide containing two consensus κB sites (5′-
GCTACAAGGGACTTTCCGCTGGGGACTTTCCAGGGAGG-3′; or with NF-Y loading 
control (5′-GATTTTTTCCTGATTGGTTAAA-3′; 5′-
ACTTTTAACCAATCAGGAAAAA-3′) in binding buffer [10mM Tris-Cl (pH 7.5), 50mM 
NaCl, 10% glycerol, 1% NP-40, 1mM EDTA, 0.1mg/mL Poly(deoxyinosinic-
deoxycytidylic)], in a final reaction of 6 μL. The reaction mixtures were run on a non-
denaturing 5% acrylamide (30:0.8) gel containing 5% glycerol and 1X TGE buffer [24.8mM 
Tris, 190 mM glycine, 1mM EDTA] at 200 V for 2 hours. The gel was visualized by 
Amersham Typhoon Scanner (GE Healthcare Life Sciences) and analyzed in ImageQuant 
TL software, in which the NF-Y loading control gel was used to normalize for loading 
variability.
Immunoprecipitation—Whole cell extracts (WCE) were lysed with RIPA buffer 
containing 1mM PMSF and 1mM DTT. Anti-RelA antibody (Santa Cruz Biotechnology, 
sc-372G) was conjugated to prewashed magnetic protein-G beads (Life Technologies 
Dynabeads) for 30-min at room temperature followed by addition unstimulated WCE in 
RIPA buffer containing 1mM PMSF and 1mM DTT and incubation overnight (~16-hr). The 
beads were then washed thoroughly with 1X TBS-T buffer and IP samples were eluted with 
1X SDS-sample buffer containing 5% β-mercaptoethanol. Samples were resolved on SDS-
PAGE and western blotting with antibodies specific for anti-RelA, anti-IκBα, anti-IκBβ, 
and anti-p50.
RNA isolation and sequencing (RNA-seq)—MEF cells at ~80% confluence were 
serum-starved by overnight incubation in Dulbecco’s Modified Eagle’s Medium 
supplemented with 0.5% bovine calf serum (BCS), 1% penicillin-streptomycin and 1% L-
Glutamine prior to stimulation. For chromatin-associated RNA-seq (caRNA-seq), nascent 
RNA transcripts were prepared from the chromatin fraction (Tong et al., 2016) using TRIzol 
according to the manufacturer’s instruction (ThermoFisher Scientific) and purified using 
Direct-zol RNA Microprep Kit (Zymo Research cat#R2060). RNA libraries were prepared 
from ribo-depleted using KAPA Stranded RNA-Seq Kit with RiboErase (KAPA Biosystems, 
cat#KK8483) with 400ng of starting total RNA material. For polyA+RNA-seq analysis, total 
RNA was isolated with the QIAGEN RNeasy Mini Kit according to the manufacturer’s 
instructions, quantified using Epoch Spectrophotometer System (Biotek), and purified from 
1 μg of starting total RNA material using oligo (dT) magnetic beads before fragmenting at 
high temperature with divalent cations. Complementary DNA libraries were generated using 
KAPA Stranded mRNA-Seq Kit (KAPA Biosystems, cat#KK8421), and quantitation was 
performed using Qubit 2.0 fluorometer using dsDNA BR assay kit #Q32853. Sequencing 
was performed on Illumina HiSeq 2000 and HiSeq 4000 with single-end 50-bp sequencing, 
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according to manufacturer’s recommendations and prepared by Broad Stem Cell Research 
Center core facility at the University of California, Los Angeles.
RNA-seq data analysis—Reads were aligned with STAR to Gencode mouse mm10 
genome and RefSeq genes and featureCounts were used to obtain aligned raw counts. Only 
uniquely mapped reads with a mapping quality score of ≥ 20 were kept for further analysis, 
using samtools. Read counts were normalized for library size and transcript length by 
conversion to RPKM and gene below the maximum RPKM < 1 were excluded from 
downstream analysis. DESeq2 was used identify induced genes for subsequent analysis 
using the following criteria: ≥ 2-fold increase in expression at any one time point over basal 
with FDR threshold of 0.01. Principal components were calculated with prcomp package 
and plotted with ggplot. caRNA-seq and polyA+RNA-seq heatmaps were plotted using 
pheatmap package. HOMER (Heinz et al., 2010) was used to assess for enrichment of de 
novo and known transcription factor binding motifs for NFκB dependent genes with 
promoter sequences 1 kB upstream and 0.3 kB downstream of the transcription start site. An 
in-depth description of this software can be found at homer.ucsd/edu/homer. Gene ontology 
analysis in biological processes for NFκB target genes were performed using Enrichr (Chen 
et al., 2013; Kuleshov et al., 2016). The 5 most enriched GO terms were selected for NFκB-
dependent genes.
Chromatin immunoprecipitation and sequencing (ChIP-seq)—MEF cells (8 × 106 
cells per plate) were serum-starved overnight with 0.5% BCS medium, then stimulated with 
10ng/mL TNF at indicated time points. For ChIP, cells were double cross-linked with 
100mM disuccinimidyl glutarate/PBS solution (DSG, ThermoFisher Scientific #20593) for 
30-min followed by 1% methanol-free Formaldehye/PBS solution (ThermoFisher Scientific 
#28908) for 15-min. Cross-linked cells were quenched with 125mM Glycine for 5 min and 
washed twicewith cold PBS followed by snap freezing with dry ice. The cell pellets were 
thawed and lysed in Lysis Buffer 1, on ice. Cells were briefly sonicated with Diagenode 
Bioruptor 300 sonication system (medium power, 15 s ON/15 s OFF, 2 cycles) in Diagenode 
1.5mL TPX microtubes (100 μl-max 300 μl/tube). After centrifugation, cell pellets were 
lysed in Lysis Buffer 2 and incubated for 10 min at room temperature. Following 
centrifugation, cell nuclear pellets were lysed in Lysis Buffer 3. Nuclear lysates were 
sonicated with Diagenode Bioruptor 300 sonication system (low power, 30 s ON/30 s OFF, 
12 cycles) in Diagenode 1.5mL TPX microtubes. Sonication was stopped every 4 cycles for 
incubation on ice for 1 min, gentle inversion and pulse-spin. Sonicated nuclear supernatant 
containing DNA fragments were consolidated with the same sample into a single 1.5 mL 
polypropelene tube. The lysates were centrifuged at max speed for 10 min at 4°C. The 
supernatants were transferred to 2 mL no-stick microtubes (Phenix Research cat# MH-820S) 
with 3 volumes of Dilution buffer and 5 mg anti-RelA antibody (Santa Cruz Biotechnology, 
sc-372), incubated overnight at 4°C. Next day, antibody-chromatin complexes were 
incubated with 30 μL magnetic protein G beads (Life Technologies Dynabeads protein G 
#1004D) for 5 hours at 4°C. Chromatin-immunoprecipitates were washed 3 times (4 min 
wash at 4°C) with each of the following buffer in this order: low-salt wash buffer, high-salt 
wash buffer, LiCl buffer, and TE buffer. ChIP DNA was eluted in elution buffer overnight at 
65°C. 1% inputs and ChIP DNA fragments were subjected to reverse cross-linking, RNase A 
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digestion (50 μg), Proteinase K digestion (50 μg), and purification with AMPure XP beads 
(Beckman Coulter). Input DNA samples were quantified with dsDNA BR assay kit 
#Q32853, and ChIP DNA samples were quantified with dsDNA HS assay kit (Q32854). 
Quantitation was performed using Qubit 2.0 fluorometer. ChIP-Seq DNA libraries were 
prepared from 5ng of Inputs or ChIP DNA using NEBNext Ultra DNA Library Prep Kit for 
Illumina (New England BioLabs, # E7370L).
ChIP Buffer composition
Lysis Buffer 1: 50mM HEPES-KOH (pH 7.6), 140mM NaCl, 1mM EDTA, 10% 
Glyercol, 0.5% NP-40, 0.25% Triton X-100 [with freshly added 1X EDTA-free 
protease inhibitors].
Lysis Buffer 2: 10mM Tris-Cl (pH 8.0), 200mM NaCl, 1mM EDTA, 0.5mM EGTA 
[with freshly added 1X EDTA-free protease inhibitors].
Lysis Buffer 3: 10mM Tris-Hcl (pH 8.0), 100mM NaCl, 1mM EDTA, 0.5mM EGTA, 
0.1% Na Deoxycholate, 0.5% N-lauroylsarcosine sodium salt, 0.2% SDS [with 
freshly added 1X EDTA-free protease inhibitors].
Dilution Buffer: 10mM Tris-Cl (pH 8.0), 160mM NaCl, 1mM EDTA, 0.01% SDS, 
1.2% Triton X-100 [with freshly added 1X EDTA-free protease inhibitors].
Low Salt Wash Buffer: 50mM HEPES-KOH (pH 7.6), 140mM NaCl, 1mM EDTA, 
1% Triton X-100, 0.1% Na Deoxycholate, 0.1% SDS [with freshly added 0.5X 
EDTA-free protease inhibitors].
High Salt Wash Buffer: 50mM HEPES-KOH (pH 7.6), 500mM NaCl, 1mM EDTA, 
1% Triton X-100, 0.1% Na Deoxycholate, 0.1% SDS [with freshly added 0.5X 
EDTA-free protease inhibitors].
LiCl Buffer: 20mM Tris-HCl (pH 8.0), 250mM LiCl, 1mM EDTA, 0.5% Na 
Deoxycholate, 0.5% NP-40
TE Buffer: 10mM Tris-HCl (pH 8.0), 1mM EDTA
Elution Buffer: 10mM Tris-HCl (pH 8.0), 1mM EDTA, 1% SDS
ChIP-seq data analysis—Sequencing reads were aligned to the mouse mm10 genome 
and RefSeq genes using Bowtie 2 (Langmead and Salzberg, 2012) and filtered using 
Samtools. Uniquely mapped reads were used to identify peaks for each sample individually 
with MACS2 version 2.1.0 using default settings except for FDR of 0.01. Differential RelA 
binding events were plotted as heatmap using plotHeatmap from deepTools2 (Ramírez et al., 
2016). ChIP-seq peak annotation for genomic locations were plotted as pie chart using 
ChIPseeker (Yu et al., 2015). For mapping of κB elements to NFκB target genes, any TNF-
inducible RelA ChIP-seq peaks within ± 10kb from gene TSS were annotated to κB 
elements (unique half and full κB DNA sequences were annotated within the mm10 
genome) and were mapped to each RelA ChIP-seq peak centered at 500bp window (±250bp 
from each peak of κB sequence) on every gene using Bedtools intersect. Full-length κB 
elements were defined by the consensus sequence 5′GGRNNNNNYCC-3′ for unique 9, 10, 
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or 11bp DNA sequence; where R is a A or G, Y is a T or C, and N is any nucleotide. κB half 
sites were defined by the consensus sequence 5′GGR or YCC-3′ DNA sequence. κB motifs 
were extracted from UCSC mm10 genome using Biostrings and BSgenome packages. 
Mapping of κB motifs and RelA ChIP-seq peaks were visualized by ggplot2 geom_segment. 
Scatterplots and boxplots of RelA ChIP-seq data were visualized by ggplot. Wilcox.test 
function in R was used to find the statistical significance of reduced versus non-reduced 
RelA peaks (Mann-Whitney U-test). Integrative Genomics Viewer (IGV) was used to 
acquire RelA ChIP-seq tracks for example genes (Robinson et al., 2011).
GC content analysis—GC sequence information was obtained from UCSC annotation 
for mouse mm10 genome using getSeq package in R with Granges objects. GC sequences 
are analyzed for ± 300 bp from each gene TSS. Percentage of GC were plotted as bar graphs 
using ggplot2 (v3.2.1) with Tidyverse. Wilcox.test function in R (Mann-Whitney U-test) was 
used to find the statistical significance of GC content.
Computational Modeling—An ODE model was constructed representing the rate of 
change of mRNA for each gene.
dRNA
dt =
kact ⋅ RelAtn
KD
n + RelAtn
− kdeg ⋅ RelA
kact is the mRNA synthesis rate that depends on the activation strength of RelA. KD is the 
dissociation constant which quantifies the nuclear abundance of RelA activity that achieves 
half-maximal gene induction. kdeg is the degradation rate of the mRNA that relates to the 
half-life with the identity t1/2 = ln(2)/ kdeg. nhill is the Hill coefficient that describes ultra-
sensitivity in gene activation, potentially the result of the cooperative effect of multiple κB 
sites, or multiple-sequential mechanistic steps that are not explicitly represented in this 
model (e.g., NFκB binding, recruitment of PIC components, promoter opening, initiation, 
RNA Pol II CTD phosphorylation, etc. RelA is a time-dependent variable obtained by 
quantifying RelA DNA-binding activity from EMSA and linearly interpolating between 
discrete time points. Basal mRNA for a given parameter set was obtained by analytically 
solving the ODE with RelA fixed at the basal value:
RNA0 =
kact ⋅ RelA0
n
kdeg ⋅ KD
n + RelA0
n
Induced time-course response was obtained using ode23s in MATLAB (The MathWorks, 
Inc.). The distance between experimental and modeled mRNA time courses was quantified 
using a combination of Pearson correlation and MSE to take into account both dynamics and 
absolute values (dist = (1 – Pearson) + MSE). As KD, nhill, kdeg are assumed to be gene-
specific properties, unaffected by TAD mutations these were first fit to WT (RelA-wt) data 
using particle swarm optimization (PSO) to minimize the distance between modeled mRNA 
time-course and measured RNA-seq (50 particles, terminating at either 100 epochs or 
distance below 0.001). As the RNA-seq time-course did not capture a decrease in mRNA 
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levels for late-induced genes, kdeg could not be fit but was assumed to be equivalent to an 8 
hour half-life. Following the fit to the WT data KD, nhill, kdeg were fixed for data from 
mutant cells and a new kact was obtained for each TAD mutation using the same 
optimization approach.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were carried out using Excel or R (version 3.6.1). Where applicable, 
statistical significance are reported in the Figures and corresponding Figure Legends. 
Western blotting were quantified using ImageJ software and data are presented as mean + 
SD. All comparisons in sequencing data were analyzed using Wilcox.test function in R 
(Mann-Whitney U-test).
DATA AND CODE AVAILABILITY
All sequencing data presented in this publication have been deposited to the NCBI Gene 
Expression Omnibus (GEO) and accessible under SuperSeries accession number 
GSE132540, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE132540. All 
quantified RelA DNA-binding activity as RelA concentration for the model and all values 
for model parameters for each 3 replicate model runs are presented in Table S5.
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Refer to Web version on PubMed Central for supplementary material.
ACKNOWLEDGMENTS
We thank S. Basak, M. Asagiri, J.V. Almaden, and J.D. Vargas for critical discussions. K.A.N. acknowledges Ning 
Wang for help in HOMER motif analysis, Diane Lefaudeux for help with RNA-seq and ChIP-seq data analyses, and 
Yi Liu for help with BMDM isolation from RelATA/TA mutant mice. This study was supported by National 
Institute of Health grants GM117134 and AI127864 to A.H. and a University of California, Los Angeles (UCLA) 
Warsaw Fellowship to K.A.N.
REFERENCES
Bae JS, Jang MK, Hong S, An WG, Choi YH, Kim HD, and Cheong J (2003). Phosphorylation of NF-
κ B by calmodulin-dependent kinase IV activates anti-apoptotic gene expression. Biochem. 
Biophys. Res. Commun 305, 1094–1098. [PubMed: 12767944] 
Baeuerle PA, and Baltimore D (1989). A 65-kD subunit of active NF-κB is required for inhibition of 
NF-κB by I κB. Genes Dev 3, 1689–1698. [PubMed: 2691328] 
Ballard DW, Dixon EP, Peffer NJ, Bogerd H, Doerre S, Stein B, and Greene WC (1992). The 65-kDa 
subunit of human NF-κ B functions as a potent transcriptional activator and a target for v-Rel-
mediated repression. Proc. Natl. Acad. Sci. USA 89, 1875–1879. [PubMed: 1542686] 
Bao X, Indukuri H, Liu T, Liao SL, Tian B, Brasier AR, Garofalo RP, and Casola A (2010). IKKε 
modulates RSV-induced NF-κB-dependent gene transcription. Virology 408, 224–231. [PubMed: 
20961594] 
Basak S, Behar M, and Hoffmann A (2012). Lessons from mathematically modeling the NF-κB 
pathway. Immunol. Rev 246, 221–238. [PubMed: 22435558] 
Bird TA, Schooley K, Dower SK, Hagen H, and Virca GD (1997). Activation of nuclear transcription 
factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the 
p65 subunit. J. Biol. Chem 272, 32606–32612. [PubMed: 9405476] 
Ngo et al. Page 21
Cell Rep. Author manuscript; available in PMC 2020 March 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Blair WS, Bogerd HP, Madore SJ, and Cullen BR (1994). Mutational analysis of the transcription 
activation domain of RelA: identification of a highly synergistic minimal acidic activation module. 
Mol. Cell. Biol 14, 7226–7234. [PubMed: 7935437] 
Bohuslav J, Chen LF, Kwon H, Mu Y, and Greene WC (2004). p53 induces NF-κκB activation by an 
κIκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. 
Biol. Chem 279, 26115–26125. [PubMed: 15073170] 
Buss H, Dörrie A, Schmitz ML, Hoffmann E, Resch K, and Kracht M (2004a). Constitutive and 
interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein 
kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-
binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-
associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem 279, 55633–55643. 
[PubMed: 15489227] 
Buss H, Dörrie A, Schmitz ML, Frank R, Livingstone M, Resch K, and Kracht M (2004b). 
Phosphorylation of serine 468 by GSK-3b negatively regulates basal p65 NF-κB activity. J. Biol. 
Chem 279, 49571–49574. [PubMed: 15465828] 
Chen FE, Huang DB, Chen YQ, and Ghosh G (1998a). Crystal structure of p50/p65 heterodimer of 
transcription factor NF-κB bound to DNA. Nature 391, 410–413. [PubMed: 9450761] 
Chen YQ, Ghosh S, and Ghosh G (1998b). A novel DNA recognition mode by the NF-κB p65 
homodimer. Nat. Struct. Biol 5, 67–73. [PubMed: 9437432] 
Chen YQ, Sengchanthalangsy LL, Hackett A, and Ghosh G (2000). NF-κB p65 (RelA) homodimer 
uses distinct mechanisms to recognize DNA targets. Structure 8, 419–428. [PubMed: 10801482] 
Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, and Ma’ayan A (2013). Enrichr: 
interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 
128. [PubMed: 23586463] 
Cheng CS, Johnson TL, and Hoffmann A (2008). Epigenetic control: slow and global, nimble and 
local. Genes Dev 22, 1110–1114. [PubMed: 18451102] 
Cheng CS, Feldman KE, Lee J, Verma S, Huang DB, Huynh K, Chang M, Ponomarenko JV, Sun SC, 
Benedict CA, et al. (2011). The specificity of innate immune responses is enforced by repression 
of interferon response elements by NF-κB p50. Sci. Signal 4, ra11. [PubMed: 21343618] 
Cheng Z, Taylor B, Ourthiague DR, and Hoffmann A (2015). Distinct single-cell signaling 
characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation. Sci. 
Signal 8, ra69. [PubMed: 26175492] 
Cheng CS, Behar MS, Suryawanshi GW, Feldman KE, Spreafico R, and Hoffmann A (2017). Iterative 
modeling reveals evidence of sequential transcriptional control mechanisms. Cell Syst 4, 330–
343.e5. [PubMed: 28237795] 
Christian F, Smith EL, and Carmody RJ (2016). The regulation of NF-κB subunits by phosphorylation. 
Cells 5, 12.
Corton JC, Moreno E, and Johnston SA (1998). Alterations in the GAL4 DNA-binding domain can 
affect transcriptional activation independent of DNA binding. J. Biol. Chem 273, 13776–13780. 
[PubMed: 9593720] 
Dong J, Jimi E, Zhong H, Hayden MS, and Ghosh S (2008). Repression of gene expression by 
unphosphorylated NF-κB p65 through epigenetic mechanisms. Genes Dev 22, 1159–1173. 
[PubMed: 18408078] 
Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, and Schmitz ML (2009). Phosphorylation of NF-
κB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific 
proteasomal elimination. EMBO Rep 10, 381–386. [PubMed: 19270718] 
Haller D, Russo MP, Sartor RB, and Jobin C (2002). IKKβ and phosphatidylinositol 3-kinase/Akt 
participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and 
NF-κ B activation in both primary and intestinal epithelial cell lines. J. Biol. Chem 277, 38168–
38178. [PubMed: 12140289] 
Hao S, and Baltimore D (2009). The stability of mRNA influences the temporal order of the induction 
of genes encoding inflammatory molecules. Nat. Immunol 10, 281–288. [PubMed: 19198593] 
Hayden MS, and Ghosh S (2008). Shared principles in NF-κB signaling. Cell 132, 344–362. [PubMed: 
18267068] 
Ngo et al. Page 22
Cell Rep. Author manuscript; available in PMC 2020 March 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass 
CK (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory 
elements required for macrophage and B cell identities. Mol. Cell 38, 576–589. [PubMed: 
20513432] 
Hochrainer K, Racchumi G, and Anrather J (2013). Site-specific phosphorylation of the p65 protein 
subunit mediates selective gene expression by differential NF-κB and RNA polymerase II 
promoter recruitment. J. Biol. Chem 288, 285–293. [PubMed: 23100252] 
Hoffmann A, and Baltimore D (2006). Circuitry of nuclear factor κB signaling. Immunol. Rev 210, 
171–186. [PubMed: 16623771] 
Hoffmann A, Levchenko A, Scott ML, and Baltimore D (2002). The IκBNF-κB signaling module: 
temporal control and selective gene activation. Science 298, 1241–1245. [PubMed: 12424381] 
Hoffmann A, Leung TH, and Baltimore D (2003). Genetic analysis of NF-κB/Rel transcription factors 
defines functional specificities. EMBO J 22, 5530–5539. [PubMed: 14532125] 
Hoffmann A, Natoli G, and Ghosh G (2006). Transcriptional regulation via the NF-κB signaling 
module. Oncogene 25, 6706–6716. [PubMed: 17072323] 
Keegan L, Gill G, and Ptashne M (1986). Separation of DNA binding from the transcription-activating 
function of a eukaryotic regulatory protein. Science 231, 699–704. [PubMed: 3080805] 
Kovesdi I, Reichel R, and Nevins JR (1986). Identification of a cellular transcription factor involved in 
E1A transactivation. Cell 45, 219–228. [PubMed: 2938741] 
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, 
Jagodnik KM, Lachmann A, et al. (2016). Enrichr: a comprehensive gene set enrichment analysis 
web server 2016 update. Nucleic Acids Res 44 (W1), W90–W97. [PubMed: 27141961] 
Langmead B, and Salzberg SL (2012). Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 
357–359. [PubMed: 22388286] 
Lecoq L, Raiola L, Chabot PR, Cyr N, Arseneault G, Legault P, and Omichinski JG (2017). Structural 
characterization of interactions between transactivation domain 1 of the p65 subunit of NF-κB and 
transcription regulatory factors. Nucleic Acids Res 45, 5564–5576. [PubMed: 28334776] 
Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, Repaka A, Mayo MW, and Burstein E (2009). 
GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelA. Genes Dev 23, 849–
861. [PubMed: 19339690] 
Milanovic M, Kracht M, and Schmitz ML (2014). The cytokine-induced conformational switch of 
nuclear factor κB p65 is mediated by p65 phosphorylation. Biochem. J 457, 401–413. [PubMed: 
24175631] 
Mitchell S, Vargas J, and Hoffmann A (2016). Signaling via the NFκB system. Wiley Interdiscip. Rev. 
Syst. Biol. Med 8, 227–241. [PubMed: 26990581] 
Moore PA, Ruben SM, and Rosen CA (1993). Conservation of transcriptional activation functions of 
the NF-κB p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae. Mol. Cell. 
Biol 13, 1666–1674. [PubMed: 8441404] 
Moreno R, Sobotzik JM, Schultz C, and Schmitz ML (2010). Specification of the NF-κB 
transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKε. 
Nucleic Acids Res 38, 6029–6044. [PubMed: 20507904] 
Morgenstern JP, and Land H (1990). Advanced mammalian gene transfer: high titre retroviral vectors 
with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic 
Acids Res 18, 3587–3596. [PubMed: 2194165] 
Morita S, Kojima T, and Kitamura T (2000). Plat-E: an efficient and stable system for transient 
packaging of retroviruses. Gene Ther 7, 1063–1066. [PubMed: 10871756] 
Mukherjee SP, Behar M, Birnbaum HA, Hoffmann A, Wright PE, and Ghosh G (2013). Analysis of 
the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription. PLoS Biol 
11, e1001647. [PubMed: 24019758] 
Mulero MC, Wang VYF, Huxford T, and Ghosh G (2019). Genome reading by the NF-κB 
transcription factors. Nucleic Acids Res 47, 9967–9989. [PubMed: 31501881] 
Nyqvist I, Andersson E, and Dogan J (2019). Role of conformational entropy in molecular recognition 
by TAZ1 of CBP. J. Phys. Chem. B 123, 2882–2888. [PubMed: 30860376] 
Ngo et al. Page 23
Cell Rep. Author manuscript; available in PMC 2020 March 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
O’Shea JM, and Perkins ND (2008). Regulation of the RelA (p65) transactivation domain. Biochem. 
Soc. Trans 36, 603–608. [PubMed: 18631125] 
Ourthiague DR, Birnbaum H, Ortenlöf N, Vargas JD, Wollman R, and Hoffmann A (2015). Limited 
specificity of IRF3 and ISGF3 in the transcriptional innate-immune response to double-stranded 
RNA. J. Leukoc. Biol 98, 119–128. [PubMed: 25896227] 
Pandya-Jones A, Bhatt DM, Lin CH, Tong AJ, Smale ST, and Black DL (2013). Splicing kinetics and 
transcript release from the chromatin compartment limit the rate of Lipid A-induced gene 
expression. RNA 19, 811–827. [PubMed: 23616639] 
Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F, and Manke T 
(2016). deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic 
Acids Res 44 (W1), W160–W165. [PubMed: 27079975] 
Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, Black JC, Hoffmann A, 
Carey M, and Smale ST (2009). A unifying model for the selective regulation of inducible 
transcription by CpG islands and nucleosome remodeling. Cell 138, 114–128. [PubMed: 
19596239] 
Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, and Mesirov JP (2011). 
Integrative genomics viewer. Nat. Biotechnol 29, 24–26. [PubMed: 21221095] 
Sabatel H, Di Valentin E, Gloire G, Dequiedt F, Piette J, and Habraken Y (2012). Phosphorylation of 
p65(RelA) on Ser(547) by ATM represses NF-κB-dependent transcription of specific genes after 
genotoxic stress. PLoS ONE 7, e38246. [PubMed: 22715377] 
Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, Doi T, and Saiki I (2003). Tumor 
necrosis factor-a-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through 
the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem 278, 36916–36923. [PubMed: 
12842894] 
Savaryn JP, Skinner OS, Fornelli L, Fellers RT, Compton PD, Terhune SS, Abecassis MM, and 
Kelleher NL (2016). Targeted analysis of recombinant NFκB (RelA/p65) by denaturing and native 
top down mass spectrometry. J. Proteomics 134, 76–84. [PubMed: 25952688] 
Schmitz ML, and Baeuerle PA (1991). The p65 subunit is responsible for the strong transcription 
activating potential of NF-κB. EMBO J 10, 3805–3817. [PubMed: 1935902] 
Schmitz ML, dos Santos Silva MA, Altmann H, Czisch M, Holak TA, and Baeuerle PA (1994). 
Structural and functional analysis of the NF-κB p65 C terminus. An acidic and modular 
transactivation domain with the potential to adopt an α-helical conformation. J. Biol. Chem 269, 
25613–25620. [PubMed: 7929265] 
Schwabe RF, and Sakurai H (2005). IKKβ phosphorylates p65 at S468 in transactivaton domain 2. 
FASEB J 19, 1758–1760. [PubMed: 16046471] 
Siggers T, Chang AB, Teixeira A, Wong D, Williams KJ, Ahmed B, Ragoussis J, Udalova IA, Smale 
ST, and Bulyk ML (2011). Principles of dimer-specific gene regulation revealed by a 
comprehensive characterization of NF-κB family DNA binding. Nat. Immunol 13, 95–102. 
[PubMed: 22101729] 
Starczynowski DT, Reynolds JG, and Gilmore TD (2005). Mutations of tumor necrosis factor α-
responsive serine residues within the C-terminal transactivation domain of human transcription 
factor REL enhance its in vitro transforming ability. Oncogene 24, 7355–7368. [PubMed: 
16027730] 
Todaro GJ, and Green H (1963). Quantitative studies of the growth of mouse embryo cells in culture 
and their development into established lines. J. Cell Biol 17, 299–313. [PubMed: 13985244] 
Tong AJ, Liu X, Thomas BJ, Lissner MM, Baker MR, Senagolage MD, Allred AL, Barish GD, and 
Smale ST (2016). A stringent systems approach uncovers gene-specific mechanisms regulating 
inflammation. Cell 165, 165–179. [PubMed: 26924576] 
van Essen D, Engist B, Natoli G, and Saccani S (2009). Two modes of transcriptional activation at 
native promoters by NF-κB p65. PLoS Biol 7, e73. [PubMed: 19338389] 
Wang D, Westerheide SD, Hanson JL, and Baldwin AS Jr. (2000). Tumor necrosis factor α-induced 
phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem 275, 
32592–32597. [PubMed: 10938077] 
Ngo et al. Page 24
Cell Rep. Author manuscript; available in PMC 2020 March 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Werner SL, Barken D, and Hoffmann A (2005). Stimulus specificity of gene expression programs 
determined by temporal control of IKK activity. Science 309, 1857–1861. [PubMed: 16166517] 
Yoboua F, Martel A, Duval A, Mukawera E, and Grandvaux N (2010). Respiratory syncytial virus-
mediated NF-κB p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKKβ. J. 
Virol 84, 7267–7277. [PubMed: 20410276] 
Yu G, Wang LG, and He QY (2015). ChIPseeker: an R/Bioconductor package for ChIP peak 
annotation, comparison and visualization. Bioinformatics 31, 2382–2383. [PubMed: 25765347] 
Zhong H, Voll RE, and Ghosh S (1998). Phosphorylation of NF-κB p65 by PKA stimulates 
transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. 
Mol. Cell 1, 661–671. [PubMed: 9660950] 
Zhong H, May MJ, Jimi E, and Ghosh S (2002). The phosphorylation status of nuclear NF-κB 
determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625–636. [PubMed: 
11931769] 
Ngo et al. Page 25
Cell Rep. Author manuscript; available in PMC 2020 March 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Highlights
• NF-κB target gene control is defined by transcriptomics, epigenomics, and 
math modeling
• NF-κB target genes require RelA transactivation domains TA1/TA2 in AND-
or-OR logics
• For inflammatory initiators, constitutive TA2 boosts TA1’s PTM-regulated 
activity
• For inflammatory resolvers, TA1/TA2 redundancy renders context-
independent control
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Figure 1. Identifying NF-κB RelA Target Genes in the TNF Response of Murine Embryonic 
Fibroblasts (MEFs)
(A) Genome-wide binding of NF-κB RelA ChIP-seq in WT MEFs stimulated with 10 
ng/mL of TNF at 0.5 and 3 h; 9,829 RelA-binding events were identified in two independent 
replicate experiments. The heatmap shows read density along ±0.5 kB of DNA centered 
around the peak read density for each binding event and ordered by high to low read density.
(B) Left panel: normalized RelA ChIP-seq density over identified peaks within the genome. 
Right panel: pie chart shows where RelA peaks are found to be located.
(C) Genome browser tracks of two replicates (r1 and r2) of RelA ChIP-seq peaks in WT 
MEFs for two known NF-κB target genes, Nfkbia and Cxcl10.
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(D) Heatmap of the relative induced expression of 419 nascent transcripts measured by 
caRNA-seq analysis, whose maximal induced expression was ≥1 RPKM and ≥2-fold over 
basal. Blue to red indicate low to high expression levels, respectively. Of these 419 genes, 
229 genes were protein coding and NF-κB dependent, as their maximal expression was 
<50% in crel−/− rela−/− compared with WT MEFs. The heatmap of gene expression is 
ordered by high to low NF-κB dependence.
(E) De novo motif and gene ontology analyses for NF-κB-dependent genes identified the 
most highly enriched motif (within −1.0 to 0.3 kB of the TSS) and GO terms (using Enrichr 
Ontologies tool [Kuleshov et al., 2016]). For NF-κB-independent genes, top motifs and GO 
terms showed substantially less significance.
(F) Line plots of chromatin-associated RNA (caRNA) abundance in RPKM for known NF-
κB target genes, Nfkbia and Cxcl10.
(G) Heatmap of mature mRNA (polyA+ RNA-seq) relative induced expression, as in (D), for 
113 NF-κB target genes, which were defined by the presence of a RelA ChIP-seq peak and 
TNF-inducible NF-κB-dependent caRNA expression. Two biological replicates of WT 
MEFs are shown, ordered by their peak time of expression.
(H) Heatmap of the relative induced expression of nascent transcripts determined by 
caRNA-seq for these 113 NF-κB-dependent genes shown in the same order as in (G).
(I) A map of 297 RelA-binding peaks identified by ChIP-seq for each of the 113 NF-κB 
target genes within ±10 kB of the TSS, shown in the same order as in (G) and (H).
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Figure 2. A RelA Genetic Complementation System for Studying the Control of Endogenous NF-
κB RelA Target Genes
(A) Schematic of the domain structure of the mouse RelA protein (with relevant amino acid 
numbers) and the primary cells to be complemented and the experimental assays to be 
performed.
(B) Genome browser tracks of RelA binding events on the Nfkbia and Cxcl10 genes in WT 
MEFs and p53−/− crel−/− rela−/− MEFs reconstituted with RelA-wt, data from two 
independent experiments (r1 and r2) are shown.
(C) Heatmap of the read density along ±0.5 kB of RelA ChIP-seq peaks after 0.5 h of TNF 
treatment for 104 genes identified as NF-κB-dependent genes in WT MEFs and p53−/− crel
−/−
 rela−/− MEFs reconstituted with RelA-wt.
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(D) Line plots of mRNA expression in RPKM of Nfkbia and Cxcl10 genes analyzed by 
polyA+ RNA-seq.
(E) Heatmap of relative induced expression in reconstituted RelA-wt and empty vector (EV) 
in p53−/− crel−/− rela−/− MEFs, as determined by polyA+ RNA-seq. Two independent 
experiments are shown.
(F) A map of the NF-κB binding sites (kB DNA sequences) within each of the 223 RelA 
ChIP-seq peaks identified with an FDR < 0.01 and associated with the 104 NF-κB target 
genes. Full κB elements refer to 9-, 10-, and 11-bp sequences conforming to the consensus: 
5′-GGR(N3–5)YCC-3′, where R = A or G; Y = C or T; N = any nucleotide (A, C, G, or T). 
Half-κB elements refer to 5′-GGR-3′ and 5′-YCC-3′.
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Figure 3. High-Affinity Binding by RelA Is Required for the TNF-Induced Expression of All NF-
κB Target Genes
(A) Schematic representation of the targeted mutations in the DNA binding mutant of 
murine RelA (R35A, Y36A, and E39A).
(B) Schematic of the κB DNA contacts made by RelA:p50 NF-κB heterodimer, adapted 
from Chen et al. (1998a). The heterodimer structure reveals base-specific contacts made by 
specific amino acids in the RelA protein, indicating the critical roles of R35, Y36, and E39. 
Arrows denote hydrogen bonds; brown ovals indicate Van der Waals contacts.
(C) Protein expression of RelA, IκBβ, IκBα, and histone 3 as loading control, by 
immunoblot in unstimulated cells genetically complemented with indicated EV, RelA-wt, 
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and RelADB. Quantified protein expression is shown on the right. Error bars represent the 
standard deviation from two independent experiments.
(D) Analysis of nuclear NF-κB activity by EMSA with κB and NF-Y (loading control) 
probes of nuclear extracts prepared at indicated times after TNF stimulation of genetically 
complemented cells shown in (C). The data are representative of two independent 
experiments. *NS, non-specific band.
(E) Heatmap density shows RelA ChIP-seq peaks at 9,829 locations defined in Figure 1A, in 
genetically complemented (RelA-wt and RelADB) p53−/− crel−/− rela−/− MEFs in response to 
0.5 h of TNF stimulation.
(F) A map of RelA binding events associated with 104 NF-κB target genes indicating 
whether RelA binding is reduced ≥2-fold in the RelADB mutant (red bar).
(G) Quantification and comparison of RelA peaks shown in (F). Averaged normalized 
counts from two replicates of RelA ChIP-seq experiments in RelA-wt or RelADB expressing 
MEFs are plotted to compare RelA peaks that are highly dependent on high-affinity binding 
by RelA versus those that are less dependent. For each category, Mann-Whitney U-test 
results indicate that peaks less dependent on high-affinity binding by RelA show a lower 
read count in RelA-wt control cells.
(H) Correlation between RelA ChIP-seq peaks and protein-binding microarray (PBM)-
determined z-scores of the strongest-κB binding-site sequences for RelA:p50 and 
RelA:RelA dimers retrieved from Siggers et al (2011). Of the seven 10-bp κB site sequences 
within not-reduced RelA peaks; the five with the strongest z-scores were plotted.
(I) Heatmap for the transcriptional TNF response of the 104 target genes in genetically 
complemented RelA-wt and RelADB cells, analyzed by polyA+ RNA-seq.
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Figure 4. The RelA C-Terminal Portion Is Required for TNF Induction of All NF-κB Target 
Genes
(A) Schematic illustrates the RelA variants to be tested: RelA C-termΔ (aa 1–325) and RelA 
TADΔ (aa 1–428).
(B) Protein expression of RelA, IκBβ, IκBα, and actin as loading controls in the indicated, 
unstimulated cells assayed by immunoblotting.
(C) Analysis of nuclear NF-κB activity by EMSA with κB and NF-Y (loading control) 
probes of nuclear extracts prepared at the indicated times after TNF stimulation of 
genetically complemented cells shown in (B). The data are representative of two 
independent experiments.
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(D) Line plots of mRNA expression for NF-κB target genes, Nfkbia and Cxcl10, in response 
to TNF in the same cells.
(E) PCA plot of all 104 NF-κB target genes in response to TNF in the same cells.
(F) Heatmap of the transcriptional response to TNF of the 104 target genes in the same cells. 
Relative induced expression is shown.
The data shown in (D), (E), and (F) are averaged RPKM from two independent polyA+ 
RNA-seq experiments.
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Figure 5. RelA Transactivation Domains TA1 and TA2 Both Contribute to the TNF Response of 
NF-κB Target Genes
(A) The schematic illustrates the RelA variants to be tested: a deletion mutant of TA1, a 
CBP-interaction mutant of TA2 (TA2CI) and a combination mutant.
(B) Protein expression of RelA and α-tubulin as loading control, in indicated unstimulated 
cells assayed by immunoblotting with antibodies specific to RelA and α-Tubulin.
(C) Analysis of nuclear NF-κB activity by EMSA with κB and NF-Y (loading control) 
probes of nuclear extracts prepared at the indicated times after TNF stimulation of 
genetically complemented cells shown in (B). The data are representative of two 
independent experiments.
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(D) Line plots of mRNA expression for Nfkbia and Cxcl10 genes in response to TNF 
stimulation in the same cells.
(E) PCA plot of all 104 NF-κB target genes in response to TNF in the same cells.
(F) Heatmap of the transcriptional response of the 104 target genes in the same cells. 
Relative induced expression is shown.
The data shown in (D), (E), and (F) are the averaged RPKM from two independent 
experiments of EV, RelA-wt, TADΔ, and TA1Δ and 1 polyA+ RNA-seq replicate of TA2CI 
and TA2CITA1Δ.
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Figure 6. A Math Model-Aided Analysis Reveals Gene-Specific Requirements for TA1 and TA2
(A) Schematic of the ordinary differential equation (ODE) used to obtain simulated mRNA 
dynamics from quantified NF-κB activity time courses.
(B) Schematic of the particle swarm optimization (PSO) pipeline used to quantify the 
activation strengths (kact) for TAD mutants. First KD, nhill, kdeg are fit to RelA-wt data with 
kact = 1. The identified parameters are then maintained with the new kact fit for each TAD 
mutant to obtain the remaining activation strength (see Method Details).
(C) Experimental (left, RNA-seq) and simulated best-fit mRNA time-course (middle) 
heatmaps, along with identified kact for TA2CI (yellow) and TA1Δ (pink). kact is shown 
relative to RelA-wt with brighter colors indicating closer activity to RelA-wt (no effect of 
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mutation) and white indicating complete loss of activity in the mutant (kact = 0). Gray 
indicating a fit with ln (dist) < − 2:5 (see Method Details) was not found.
(D) Scatterplot of kact for TA2CI and TA1Δ for 76 genes with a good fit in (C). Center color 
represents the effect of either a single mutation (from green kact = 1 with no change from 
RelA-wt and redundancy with respect to a single mutation, to blue kact = 0 where either 
mutation abrogates gene induction and both domains work synergistically to achieve full 
gene activation). Border colors represent an off-diagonal effect in which a gene shows a 
specific loss of induction in TA2CI (pink) or TA1Δ (yellow). Gray lines indicate the standard 
deviation of kact from three repeated runs of optimization pipeline.
(E) Bar graphs of kact (relative to the mean RelA-wt kact) for RelA-wt, TA2CI, TA1Δ, and 
TA2CITA1Δ mutants, shown for four example genes arranged to indicate their relative 
positions in (D). Error bars indicate standard deviations of kact from three repeated runs of 
optimization pipeline.
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Figure 7. A Knockin Mouse Reveals that the Dual TAD Requirement Pertains to Other Cell 
Types and Stimuli
(A) Venn diagrams display overlap in induced transcriptional response in MEFs and 
BMDMs. Induced genes satisfy two criteria: log2 fold-change ≥2 and maximum RPKM >1, 
by polyA+ RNA-seq during a 3-h time-course analysis. In response to TNF, 159 genes are 
induced in WT MEFs and 310 are induced in WT BMDMs (left panel). In response to LPS, 
939 genes are induced in WT MEFs and 805 induced genes in WT BMDMs (right panel).
(B) Heatmaps of relative expression of the induced genes in WT and RelATA/TA mutant 
MEFs or BMDMs in response to TNF (left panel) or LPS (right panel). Gene names and 
data plotted in heatmaps are listed in Tables S2A and S2B for TNF and LPS, respectively.
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(C) RelA-TAD dependence of induced genes: percentage of peak expression in RelATA/TA 
mutant versus WT. Genes are rearranged by their TAD dependence in TNF stimulation and 
further re-arranged in each category by LPS response. Genes induced by TNF in MEFs and 
BMDMs (left panel). Gene names and data plotted in heatmap are listed in Table S2C. 
Genes induced by LPS in MEFs and BMDMs. Gene names and data plotted in heatmap are 
listed in Table S2D (right panel).
(D) Venn diagrams displays overlap in induced transcriptional response to TNF and LPS. In 
WT MEFs, 159 genes were induced by TNF and 939 by LPS (left panel). In WT BMDMs, 
310 genes were induced by TNF and 805 were induced by LPS (right panel).
(E) Heatmaps of relative expression of TNF- versus LPS-induced genes in WT and 
RelATA/TA mutant MEFs (left panel) or BMDMs (right panel). Gene names and data plotted 
in the heatmap are listed in Tables S3A and S3B for MEFs and BMDMs, respectively.
(F) NF-κB dependence of induced genes: percentage of peak expression in RelATA/TA 
mutant versus WT. Genes induced by MEFs by TNF and LPS (left panel). Gene names and 
data plotted in heatmap are listed in Table S3C. Genes induced by BMDMs by TNF and 
LPS (right panel). Gene names and data plotted in heatmap are listed in Table S3D.
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